Insights

Cutting-edge DDR platform Artios leverages its specialized DcoDeR platform to develop innovative medicines targeting DNA damage response pathways used by cancer cells, offering a unique value proposition to potential partners and investors.

Strategic partnerships With collaborations with Merck KGaA and Novartis, Artios enhances its credibility and market positioning, creating opportunities for cross-selling and co-development initiatives within the pharmaceutical industry.

High unmet needs addressed Artios' pipeline focuses on solid tumor indications with high unmet medical needs, presenting an opportunity for targeted sales and partnerships with healthcare providers seeking advanced treatment options.

Financial stability and growth Having received significant funding and with revenues ranging between $10M to $50M, Artios demonstrates financial health that can attract potential investors and stakeholders looking to engage with a stable and growing biotechnology company.

Cutting-edge technology stack Artios' use of technologies like Microsoft, Cloudflare, and MySQL signifies a commitment to advanced tools and infrastructure, appealing to tech-savvy clients seeking partners with modern capabilities.

Similar companies to Artios

Artios Tech Stack

Artios uses 8 technology products and services including Optimise, Cloudflare, MySQL, and more. Explore Artios's tech stack below.

  • Optimise
    Affiliate Advertising Networks
  • Cloudflare
    Content Management System
  • MySQL
    Database
  • Microsoft
    Miscellaneous
  • Smartsheet
    Project Management
  • reCAPTCHA
    Security
  • Vimeo
    Video Players
  • RankMath SEO
    Web Platform Extensions

Media & News

Artios's Email Address Formats

Artios uses at least 2 format(s):
Artios Email FormatsExamplePercentage
First.Last@artiospharma.comJohn.Doe@artiospharma.com
61%
FLast@artiospharma.comJDoe@artiospharma.com
25%
F.Last@artiospharma.comJ.Doe@artiospharma.com
8%
Last@artiospharma.comDoe@artiospharma.com
2%
FirstL@artiospharma.comJohnD@artiospharma.com
1%
L.First@artiospharma.comD.John@artiospharma.com
1%
FL@artiospharma.comJD@artiospharma.com
1%
LastFi@artiospharma.comDoeJo@artiospharma.com
1%
FLast@artios.comJDoe@artios.com
100%

Frequently Asked Questions

Where is Artios's headquarters located?

Minus sign iconPlus sign icon
Artios's main headquarters is located at The Glenn Berge Building Babraham Research Campus Cambridge, CB22 3FH GB. The company has employees across 5 continents, including EuropeNorth AmericaOceania.

What is Artios's phone number?

Minus sign iconPlus sign icon
You can contact Artios's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Artios's official website and social media links?

Minus sign iconPlus sign icon
Artios's official website is artios.com and has social profiles on LinkedIn.

How much revenue does Artios generate?

Minus sign iconPlus sign icon
As of October 2024, Artios's annual revenue reached $35M.

What is Artios's SIC code NAICS code?

Minus sign iconPlus sign icon
Artios's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Artios have currently?

Minus sign iconPlus sign icon
As of October 2024, Artios has approximately 51 employees across 5 continents, including EuropeNorth AmericaOceania. Key team members include Chief Scientific Officer: G. S.Chief Financial Officer: A. A.Vice President Of Clinical Science: D. H.. Explore Artios's employee directory with LeadIQ.

What industry does Artios belong to?

Minus sign iconPlus sign icon
Artios operates in the Biotechnology Research industry.

What technology does Artios use?

Minus sign iconPlus sign icon
Artios's tech stack includes OptimiseCloudflareMySQLMicrosoftSmartsheetreCAPTCHAVimeoRankMath SEO.

What is Artios's email format?

Minus sign iconPlus sign icon
Artios's email format typically follows the pattern of . Find more Artios email formats with LeadIQ.

How much funding has Artios raised to date?

Minus sign iconPlus sign icon
As of October 2024, Artios has raised $153M in funding. The last funding round occurred on Jul 27, 2021 for $153M.

When was Artios founded?

Minus sign iconPlus sign icon
Artios was founded in 2016.
Artios

Artios

Biotechnology ResearchCambridge, United Kingdom51-200 Employees

Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. Together with our strategic partnerships with Merck KGaA and Novartis, and research collaborations with premiere institutions like Cancer Research UK, The Institute of Cancer Research, The Netherlands Cancer Institute, and the Crick Institute we are pioneering validated approaches to DDR drug discovery. Visit our website at https://www.artios.com/ for more information.
Artios is based at the Babraham Campus in Cambridge, UK. If you are interested in working at Artios and have the qualities to be part of our team, please submit your application via our website. We are also very mindful of scams that involve recruitment. At this time please note we are currently not working with any third parties in India for recruitment.

Section iconCompany Overview

Headquarters
The Glenn Berge Building Babraham Research Campus Cambridge, CB22 3FH GB
Phone number
Website
artios.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $153M

    Artios has raised a total of $153M of funding over 5 rounds. Their latest funding round was raised on Jul 27, 2021 in the amount of $153M.

  • $10M$50M

    Artios's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $153M

    Artios has raised a total of $153M of funding over 5 rounds. Their latest funding round was raised on Jul 27, 2021 in the amount of $153M.

  • $10M$50M

    Artios's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.